Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth (2020)
Source: Gene Therapy. Unidades: ICB, FM
Subjects: BIOLOGIA CELULAR, NEOPLASIAS PROSTÁTICAS, QUIMIOTERAPIA, CÉLULAS CULTIVADAS DE TUMOR, LEUCOPENIA ANIMAL, CAMUNDONGOS, MODELOS ANIMAIS
ABNT
TAMURA, Rodrigo Esaki et al. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth. Gene Therapy, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41434-019-0071-x. Acesso em: 05 maio 2026.APA
Tamura, R. E., Lana, M. V. G., Costanzi-Strauss, E., & Strauss, B. E. (2020). Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth. Gene Therapy. doi:10.1038/s41434-019-0071-xNLM
Tamura RE, Lana MVG, Costanzi-Strauss E, Strauss BE. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth [Internet]. Gene Therapy. 2020 ;[citado 2026 maio 05 ] Available from: https://doi.org/10.1038/s41434-019-0071-xVancouver
Tamura RE, Lana MVG, Costanzi-Strauss E, Strauss BE. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth [Internet]. Gene Therapy. 2020 ;[citado 2026 maio 05 ] Available from: https://doi.org/10.1038/s41434-019-0071-x
